|
|
|
Compounds called defensins-known to prevent viruses from entering cells-appear to do so by preventing the virus from merging to cells' outer membrane, according to a study by researchers at the National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute, both of the National Institutes of Health, and the University of California at Los Angeles.
The study, appearing in the online issue of September 11 Nature Immunology, also received funding from NIH's National Center for Research Resources. This discovery provides a basic understanding of a first-line defense against such viruses as HIV and the influenza virus, said Duane Alexander, M.D., Director of the NICHD. This finding may ultimately lead to new strategies for preventing viral illness, and to increased understanding of why some individuals are more resistant to certain kinds of viral infection than are other individuals.
Message posted by: Rashmi Nemade
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|